Literature DB >> 21835462

Mechanical and biological properties of keratose biomaterials.

Roche C de Guzman1, Michelle R Merrill, Jillian R Richter, Rawad I Hamzi, Olga K Greengauz-Roberts, Mark E Van Dyke.   

Abstract

The oxidized form of extractable human hair keratin proteins, commonly referred to as keratose, is gaining interest as a biomaterial for multiple tissue engineering studies including those directed toward peripheral nerve, spinal cord, skin, and bone regeneration. Unlike its disulfide cross-linked counterpart, kerateine, keratose does not possess a covalently cross-linked network structure and consequently displays substantially different characteristics. In order to understand its mode(s) of action and potential for clinical translatability, detailed characterization of the composition, physical properties, and biological responses of keratose biomaterials are needed. Keratose was obtained from end-cut human hair fibers by peracetic acid treatment, followed by base extraction, and subsequent dialysis. Analysis of lyophilized keratose powder determined that it contains 99% proteins by mass with amino acid content similar to human hair cortex. Metallic elements were also found in minute quantities. Protein oxidation led to disulfide bond cleavage and drastic reduction of free thiols due to conversion of sulfhydryl to sulfonic acid, chain fragmentation, and amino acid modifications. Mass spectrometry identified the major protein constituents as a heterogeneous mixture of 15 hair keratins (type I: K31-35 and K37-39, and type II: K81-86) with small amounts of epithelial keratins which exist in monomeric, dimeric, multimeric, and even degraded forms. Re-hydration with PBS enabled molecular assembly into an elastic solid-like hydrogel. Highly-porous scaffolds formed by lyophilization of the gel had the compression behavior of a cellular foam material and reverted back to gel upon wetting. Cytotoxicity assays showed that the EC50 for various cell lines were attained at 8-10 mg/mL keratose, indicating the non-toxic nature of the material. Implantation in mouse subcutaneous tissue pockets demonstrated that keratose resorption follows a rectangular hyperbolic regression with 92% degradation by an 8-week time point. Keratose was shown to integrate with the host tissue as evidenced by infiltration of leukocytes and fibroblasts, bulk material angiogenesis, and minimal fibrous encapsulation. Tissue response benchmarks were superior in keratose compared to the control PLGA 90:10 mesh. Finally, the degraded keratose was observed to remodel with the natural collagen extracellular matrix, verifying the benefit of using keratose as a temporary matrix for regenerative medicine applications.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835462     DOI: 10.1016/j.biomaterials.2011.07.054

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  27 in total

1.  A human hair keratin hydrogel scaffold enhances median nerve regeneration in nonhuman primates: an electrophysiological and histological study.

Authors:  Lauren A Pace; Johannes F Plate; Sandeep Mannava; Jonathan C Barnwell; L Andrew Koman; Zhongyu Li; Thomas L Smith; Mark Van Dyke
Journal:  Tissue Eng Part A       Date:  2013-11-15       Impact factor: 3.845

2.  In vitro characterization and ex vivo surgical evaluation of human hair keratin films in ocular surface reconstruction after sterilization processing.

Authors:  Maria Borrelli; Stephan Reichl; Yaqing Feng; Marc Schargus; Stefan Schrader; Gerd Geerling
Journal:  J Mater Sci Mater Med       Date:  2012-09-27       Impact factor: 3.896

3.  Cellulose, Chitosan and Keratin Composite Materials: Facile and Recyclable Synthesis, Conformation and Properties.

Authors:  Chieu D Tran; Tamutsiwa M Mututuvari
Journal:  ACS Sustain Chem Eng       Date:  2016-02-08       Impact factor: 8.198

4.  Alkylation of human hair keratin for tunable hydrogel erosion and drug delivery in tissue engineering applications.

Authors:  Sangheon Han; Trevor R Ham; Salma Haque; Jessica L Sparks; Justin M Saul
Journal:  Acta Biomater       Date:  2015-05-18       Impact factor: 8.947

5.  In Vivo Evaluation of Three-Dimensional Printed, Keratin-Based Hydrogels in a Porcine Thermal Burn Model.

Authors:  Javier Navarro; Ryan M Clohessy; Robert C Holder; Alexis R Gabard; Gregory J Herendeen; Robert J Christy; Luke R Burnett; John P Fisher
Journal:  Tissue Eng Part A       Date:  2020-01-09       Impact factor: 3.845

6.  HPLC-MS/MS method for quantification of paclitaxel from keratin containing samples.

Authors:  Emily A Turner; Alexandra C Stenson; Saami K Yazdani
Journal:  J Pharm Biomed Anal       Date:  2017-03-10       Impact factor: 3.935

7.  Keratin Hydrogel Enhances In Vivo Skeletal Muscle Function in a Rat Model of Volumetric Muscle Loss.

Authors:  J A Passipieri; H B Baker; Mevan Siriwardane; Mary D Ellenburg; Manasi Vadhavkar; Justin M Saul; Seth Tomblyn; Luke Burnett; George J Christ
Journal:  Tissue Eng Part A       Date:  2017-04-14       Impact factor: 3.845

8.  Reduction of ectopic bone growth in critically-sized rat mandible defects by delivery of rhBMP-2 from kerateine biomaterials.

Authors:  Christine J Kowalczewski; Seth Tombyln; David C Wasnick; Michael R Hughes; Mary D Ellenburg; Michael F Callahan; Thomas L Smith; Mark E Van Dyke; Luke R Burnett; Justin M Saul
Journal:  Biomaterials       Date:  2014-01-15       Impact factor: 12.479

9.  Effects of Tunable Keratin Hydrogel Erosion on Recombinant Human Bone Morphogenetic Protein 2 Release, Bioactivity, and Bone Induction.

Authors:  David Joshua Cohen; Sharon L Hyzy; Salma Haque; Lucas C Olson; Barbara D Boyan; Justin M Saul; Zvi Schwartz
Journal:  Tissue Eng Part A       Date:  2018-09-06       Impact factor: 3.845

10.  Development of keratin nanoparticles for controlled gastric mucoadhesion and drug release.

Authors:  Zhongjun Cheng; Xiaoliang Chen; Dongliang Zhai; Feiyan Gao; Tingwang Guo; Wenfeng Li; Shilei Hao; Jingou Ji; Bochu Wang
Journal:  J Nanobiotechnology       Date:  2018-03-19       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.